Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SRTS |
---|---|---|
09:32 ET | 932 | 3.87 |
09:36 ET | 100 | 3.83 |
09:38 ET | 100 | 3.84 |
09:39 ET | 174 | 3.84 |
09:41 ET | 200 | 3.85 |
09:50 ET | 200 | 3.8792 |
09:52 ET | 2232 | 3.85 |
09:54 ET | 573 | 3.8799 |
10:03 ET | 5000 | 3.8301 |
10:08 ET | 300 | 3.85 |
10:12 ET | 202 | 3.84 |
10:14 ET | 1014 | 3.93 |
10:32 ET | 150 | 3.8801 |
10:42 ET | 850 | 3.894 |
11:02 ET | 100 | 3.915 |
11:29 ET | 429 | 3.93 |
11:33 ET | 200 | 3.92 |
11:36 ET | 1999 | 3.91 |
11:38 ET | 200 | 3.9 |
11:51 ET | 5716 | 3.83 |
11:54 ET | 542 | 3.83 |
11:56 ET | 782 | 3.8138 |
11:58 ET | 400 | 3.81 |
12:00 ET | 500 | 3.8 |
12:03 ET | 4211 | 3.87 |
12:05 ET | 418 | 3.84 |
12:07 ET | 459 | 3.87 |
12:16 ET | 100 | 3.86 |
12:20 ET | 502 | 3.86 |
12:21 ET | 100 | 3.86 |
12:23 ET | 129 | 3.86 |
12:30 ET | 923 | 3.84 |
12:39 ET | 300 | 3.85 |
12:45 ET | 924 | 3.85 |
12:50 ET | 791 | 3.86 |
12:52 ET | 100 | 3.87 |
12:57 ET | 200 | 3.9 |
01:06 ET | 300 | 3.8615 |
01:17 ET | 200 | 3.885 |
01:28 ET | 2390 | 3.87 |
01:30 ET | 636 | 3.86 |
01:33 ET | 2873 | 3.84 |
01:42 ET | 400 | 3.867 |
01:46 ET | 100 | 3.87 |
02:00 ET | 100 | 3.88 |
02:02 ET | 100 | 3.89 |
02:15 ET | 300 | 3.84 |
02:26 ET | 100 | 3.87 |
02:29 ET | 1400 | 3.82 |
02:36 ET | 100 | 3.87 |
02:44 ET | 259 | 3.8599 |
02:47 ET | 100 | 3.8 |
02:56 ET | 929 | 3.82 |
03:03 ET | 300 | 3.85 |
03:05 ET | 200 | 3.82 |
03:21 ET | 100 | 3.81 |
03:38 ET | 600 | 3.8101 |
03:48 ET | 100 | 3.81 |
03:54 ET | 350 | 3.84 |
03:57 ET | 100 | 3.81 |
03:59 ET | 200 | 3.8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Sensus Healthcare Inc | 64.3M | 130.4x | --- |
Spectral AI Inc | 34.5M | -1.8x | --- |
ICAD Inc | 42.2M | -4.3x | --- |
T2 Biosystems Inc | 15.0M | 0.0x | --- |
Telesis Bio Inc | 13.5M | -0.3x | --- |
Bionano Genomics Inc | 59.6M | -0.2x | --- |
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $64.3M |
---|---|
Revenue (TTM) | $24.4M |
Shares Outstanding | 16.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $0.03 |
Book Value | $2.98 |
P/E Ratio | 130.4x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 84.6x |
Operating Margin | -1.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.